Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFR2/CD309 anticorps (AA 949-953)

L’anticorps anti-VEGFR2/CD309 Polyclonal produit chez le Lapin a été validé pour WB, IF et IHC (p). Il convient pour la détection de VEGFR2/CD309 dans des échantillons provenant de Humain, Souris et Rat. }
N° du produit ABIN197240
606,15 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 17 jours ouvrables

Aperçu rapide pour VEGFR2/CD309 anticorps (AA 949-953) (ABIN197240)

Antigène

Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité

  • 341
  • 215
  • 143
  • 17
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 297
  • 67
  • 42
  • 14
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 278
  • 145
Polyclonal

Conjugué

  • 183
  • 34
  • 20
  • 16
  • 14
  • 10
  • 10
  • 8
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp VEGFR2/CD309 est non-conjugé

Application

  • 221
  • 121
  • 111
  • 111
  • 63
  • 35
  • 26
  • 26
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Épitope

    • 39
    • 34
    • 26
    • 23
    • 21
    • 16
    • 16
    • 11
    • 11
    • 10
    • 9
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 949-953

    Specificité

    The antibody detects endogenous levels of total VEGFR2 protein.

    Purification

    Affinity Chromatography using epitope-specific immunogen.

    Immunogène

    Peptide sequence around amino acids 949~953 (K-D-Y-V-G) derived from Human VEGFR2.
  • Indications d'application

    Western Blot: 1/500-1/1000. Immunofluorescence: 1/100-1/200. Immunohistochemistry on Paraffin Embedded Tissue: 1/50-1/100.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS (without Mg2+ and Ca2+), pH 7.4, containing 150 mM NaCl, 0.02 % Sodium Azide and 50 % glycerol

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    -20 °C

    Stockage commentaire

    Store the antibody (in aliquots) at -20 °C.
  • Antigène

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Autre désignation

    CD309 / VEGFR-2 / Flk-1

    Sujet

    VEGF receptor 2 is a member of a receptor tyrosine kinase family whose activation plays an essential role in a large number of biological processes such as embryonic development, wound healing, cell proliferation, migration and differentiation. Like other growth factor receptors, upon ligand binding VEGF receptor 2 dimerises and is autophosphorylated on multiple tyrosine residues. These sites can be involved in the regulation of kinase activity or serve as binding sites for SH2 and phosphotyrosine binding containing signalling proteins. Phosphorylation of Tyrosines 1054 and 1059 in the activation loop is required for activation of VEGF receptor 2 and its intrinsic tyrosine kinase activity. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.Synonyms: FLK1, KDR, Kinase NYK, Kinase insert domain receptor, Protein-tyrosine kinase receptor Flk-1, VEGF Receptor 2, VEGFR2, Vascular endothelial growth factor receptor 2

    ID gène

    3791

    NCBI Accession

    NP_002244

    UniProt

    P35968

    Pathways

    Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Chat with us!